Cargando…

Antibody levels in people with diabetes after one dose of the ChAdOx1 nCoV-19 (AZD1222) vaccine

Patients with diabetes and coexistent coronavirus disease 2019 (COVID-19) have a higher risk of COVID-19 complications. Therefore, it is critical that sustained and effective immunogenicity against COVID-19 is achieved in such patients. This study evaluates the antibody response for 56 days after th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rangsrisaeneepitak, Vimonsri, Porntharukchareon, Thachanun, Dechates, Bothamai, Sirisreetreerux, Supamas, Tawinprai, Kriangkrai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068501/
https://www.ncbi.nlm.nih.gov/pubmed/35528950
http://dx.doi.org/10.1007/s13340-022-00582-1